Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Clinical trial NCT05559879 · RECRUITING
Trial details
- NCT number
- NCT05559879
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-20
- Primary completion
- 2027-04-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.